Search

everythinglearnresearchcommunity

for

Search:↓

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Harlequin mutant mice have hair loss due to low AIF protein levels and retroviral element activity.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

AH-001 could be a safer and more effective treatment for hair loss.

The fuzzy gene is crucial for controlling hair growth cycles.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

ICAM-1 helps regulate hair growth cycles and skin remodeling.

Some patients lost hair after taking interferon alpha 2B, but it improved for some while still on the treatment and for others after stopping it.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

TGF-alpha is present in sheep and ferret skin and may affect hair growth without directly stimulating cell proliferation.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Blocking α1-integrin makes adult fibroblasts more like foetal ones, improving their movement and aiding wound healing.

Isoproterenol may help treat hair loss by activating hair follicle stem cells.

FAI is a better marker for predicting female hair loss than testosterone or SHBG alone.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Immune activities and specific genes are important in male pattern baldness.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Hair loss in male pattern baldness is linked to changes in immune cell behavior around hair follicles.

ILC1-like cells may contribute to hair loss in alopecia areata.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Interleukin-15 can help hair growth and protect hair follicles.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Integrin α6 helps identify different neural crest cell types in the skin.